After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of life and long-term prognosis have been greatly affected…
Liver diseases account for 300,000 deaths in Europe each year. With support from the Innovative Health Initiative, a collaboration of researchers, biotechnology companies and the pharmaceutical industry aim to improve the lives and health of people with hidden liver disease…
Triggered by the rising burden of liver disease, the Lancet and the European Association for the Study of the Liver (EASL) jointly arranged a Commission to explore the landscape of liver health in Europe. The culmination of this work was…
The European Association for the Study of the Liver (EASL), as part of the Healthy Livers, Healthy Lives Coalition held a policy webinar on 31 January 2024. Moderated by Nicola Bedlington and featuring esteemed speakers from around the world, this…
The DECISION project, an EU-funded research initiative, is making significant strides in understanding the complex dynamics of acute decompensation of cirrhosis and its progression to acute-on-chronic liver failure (ACLF). In a recent interview, Prof. Pierre-Emmanuel Rautou, DECISION Project Coordinator, provided…
Endowed with €12 million, the project is coordinated by Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncology, a professor of Medicine at the University of Barcelona (UB) an ICREA professor. The European Union’s THRIVE…
It is with deep sorrow that EASL announces the passing of Sir Roy Calne, a pioneer in the field of transplantation. Sir Calne, a distinguished professor of surgery at Cambridge University, passed away at the age of 93. His remarkable…
Press Release Brussels, 12 December 2023 As the European Parliament prepares for the vote on the Subcommittee on Health (SANT)’s Non-Communicable Diseases (NCDs) report, leading health organisations across the EU are actively highlighting the need for more robust public health…
Study finds people with chronic liver disease and post-liver transplantation are at higher risk of getting infected with SARS-CoV-2 after COVID-19 primary series vaccination and identifies predictive factors associated with breakthrough infection. BARCELONA—Inadequate supply and lower acceptance rate of COVID-19…
Every October, we stand united for #LiverCancerAwarenessMonth, and EASL is proud to support this vital campaign. This month is a significant opportunity to raise awareness, educate, and advocate for liver health on a global scale. It serves as a reminder…